Health equity in the implementation of genomics and precision medicine: A public health imperative.

🤖 Plain-English Summary

Recent reviews have emphasized the need for a health equity agenda in genomics research. Crucial public health activities also include engaging communities, building coalitions, improving genetic health literacy, and building a diverse workforce.

🔑 Key Findings

• To ensure that genomic discoveries can lead to improved health outcomes for all segments of the population, a health equity agenda needs to go beyond research studies.
• Advances in genomics and precision medicine have led to an increasing number of evidence-based applications that can reduce morbidity and mortality for millions of people (tier 1).
• Studies have shown lower implementation rates for selected diseases with tier 1 applications (familial hypercholesterolemia, Lynch syndrome, hereditary breast and ovarian cancer) among racial and ethnic minority groups, rural communities, uninsured or underinsured people, and those with lower education and income.

🔗 Related Resources